Shenzhen, China, July 24, 2025 (GLOBE NEWSWIRE) -- Baiya International Group Inc. (“BIYA” or the “Company”) (Nasdaq: BIYA), a human resource (“HR”) technology company utilizing its cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions, today announced that STARFISH TECHNOLOGY-FZE (“Starfish”)’s UpTop.Meme (“UpTop”) platform has officially launched on Binance Alpha (“Binance”), a premier global cryptocurrency asset platform. In July 2025, BIYA signed a stra ...

As SVP, Head of Product, Performance Media, Schobeiri will help shape Criteo's future as a platform-first business and unlock greater value for brands and agenciesNEW YORK, July 24, 2025 /PRNewswire/ -- Criteo (NASDAQ: CRTO), the global platform connecting the commerce ecosystem, today announced the appointment of Wilfried Schobeiri as Senior Vice President, Head of Product, Performance Media, reporting to Chief Product Officer Todd Parsons. Schobeiri will lead Criteo's global efforts to accelerate the evol ...

LOS ALTOS, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced the publication of pivotal trial data describing the safety and tolerability of oxylanthanum carbonate (OLC) in chronic kidney disease (CKD) patients on dialysis in the Clinical Journal of the American Society of Nephrology. The publication, entitled “A Phase 2 Clinical Tr ...

Strategic Alliance to Accelerate Enterprise Adoption of AI-Powered Cloud and Blockchain Solutions Across Southeast AsiaKUALA LUMPUR, Malaysia, July 24, 2025 (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), today announced the signing of a Memorandum of Understanding (MoU) with iSynergy Group Limited (ASX: IS3) (“iSynergy”), a Malaysian-headquartered technology company listed on the Australian Securities Exchange. This MoU establishes the framework for a strategic ...

Patent Expands Immunogenic Coverage of α-Lactalbumin-Based Vaccine PlatformTechnology Addresses Substantial Unmet Need in Preventive Oncology with Multi-Billion Dollar Market PotentialSAN JOSE, Calif., July 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and Trademark Office (USPTO) will issue U.S. Patent Number 12,370,244 on July 29, 2025, cove ...

收购交易核心条款 - 礼来公司以每股10.50美元现金加最高3美元或有价值权(CVR)的条件收购Verve Therapeutics全部流通股 [1] - 交易包含非交易型或有价值权(CVR)，该权利在达到特定里程碑时支付 [1] - 要约于2025年7月23日美国东部时间23:59到期未延期 [1] 交易执行情况 - 截至到期时间共49,882,464股(占流通股55.7%)被有效投标且未撤回 [2] - 礼来及其全资子公司Ridgeway Acquisition Corporation已接受所有有效投标股份并将及时支付 [2] - 交易预计于2025年7月25日完成 [3] 交易相关方 - 礼来法律顾问为Kirkland & Ellis LLP [3] - Verve财务顾问为Centerview Partners LLC和Guggenheim Securities LLC [3] - Verve法律顾问为Paul, Weiss, Rifkind, Wharton & Garrison LLP [3] Verve Therapeutics业务概况 - 临床阶段基因编辑公司，专注于心血管疾病治疗 [4] - 主要开发单疗程基因编辑药物替代现有慢性疗法 [4] - 三大核心项目分别靶向导致动脉粥样硬化的三种脂蛋白 [4] - VERVE-102靶向PCSK9基因，用于家族性高胆固醇血症和动脉粥样硬化心血管疾病 [4] - VERVE-201靶向ANGPTL3基因，用于难治性高胆固醇血症 [4] - VERVE-301靶向LPA基因，降低脂蛋白(a)水平 [4] 礼来公司业务概况 - 拥有近150年历史的跨国制药企业 [5] - 专注糖尿病、肥胖症、阿尔茨海默病、免疫系统疾病和癌症治疗领域 [5] - 通过生物技术、化学和基因医学推动新药研发 [5]

Telescope Innovations Selected to Join ALTA: the First US-Based Lithium Technology AcceleratorTelescope is among the first tech companies invited to the Arkansas Lithium Technology Accelerator (ALTA), engaging with industry leaders on the commercialization pathways for its lithium processing technologiesJuly 24, 2025 8:00 AM EDT | Source: Telescope Innovations Corp.Vancouver, British Columbia--(Newsfile Corp. - July 24, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE:4JU) ( ...

Matchpoint to receive up to $60 million in upfront payment and research funding, with up to $1 billion in total potential payments, including option exercise fee, development and commercial milestonesMatchpoint will lead all research activities through development candidate selection WATERTOWN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Matchpoint Therapeutics, a biotechnology company pioneering the discovery of precision covalent medicines, today announced that it has entered into an exclusive option and lic ...

SHANGHAI and HONG KONG, July 24, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, today announced the establishment of a wholly owned subsidiary, NETCLASS INTERNATIONAL PTE. LTD., in Singapore, to support its international business development in AI applications, with a focus on expanding its footprint in Southeast Asia and other global markets. The new s ...

TARRYTOWN, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the 13th annual Regeneron Prize for Creative Innovation (the “Regeneron Prize”), which recognizes and rewards outstanding creativity and talent among early-career scientists in biomedical research. Each year, top U.S. research universities nominate their most promising graduate students and postdoctoral fellows for this honor. These nominees are invited to develop and pitch their ...